The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis
Abstract
Articular chondrocyte production of nitric oxide (NO) and other inflammatory mediators, such as eicosanoids and cytokines, are increased in human osteoarthritis. The excessive production of nitric oxide inhibits matrix synthesis and promotes its degradation. Furthermore, by reacting with oxidants such as superoxide anion, nitric oxide promotes cellular injury and renders the chondrocyte susceptible to cytokine-induced apoptosis. PGE(2) exerts anabolic and catabolic effects on chondrocytes, depending on the microenvironment and physiologic condition. The increased expression of inducible NOS (iNOS) and cyclo-oxygenase-2 (COX-2) in OA chondrocytes is largely due to the increased expression of pro-inflammatory cytokines, particularly IL-1, which act in an autocrine/paracrine fashion to perpetuate a catabolic state that leads to progressive destruction of articular cartilage. The initiating factors for the production of inflammatory mediators include altered biomechanical forces; their continued production may be augmented by an increase in extracellular matrix proteins acting through ligation of surface integrins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Articular cartilage of patients with OA shows features of senescence, including increased expression of nitric oxide, pro-inflammatory cytokines, particularly IL-1β [8]; p16 [9]; activated DNA damage response; ROS secretion and SA-β-Gal activity [10].”
From Fibrates as drugs with senolytic and autophagic activity for osteoarthritis therapy (2019) · cites this paper as [8]
Citations
Cites
Biochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide
Pryor, W. A., & Squadrito, G. L. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.268.5.l699 · Cited by 1,511
Reginster, J., Deroisy, R., Rovati, L. C., Lee, R. L., Lejeune, E., Bruyère, O., Giacovelli, G., Henrotin, Y. E., Dacre, J. E., & Gosset, C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03610-2 · Cited by 1,233
Myers, P. R., Minor, R. L., Guerra, R., Bates, J. N., & Harrison, D. G. (1990) · Nature · doi:10.1038/345161a0 · Cited by 973
Inducible nitric oxide synthase: what difference does it make?
Nathan, C. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119782 · Cited by 935
Glucosamine therapy for treating osteoarthritis
Towheed, T., Maxwell, L. J., Anastassiades, T., Shea, B., Houpt, J., Welch, V. A., Hochberg, M. C., & Wells, G. A. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002946.pub2 · Cited by 688
Clancy, R. M., Leszczynska-Piziak, J., & Abramson, S. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115929 · Cited by 686
Self-citationVan'T Hof, R. J., & Ralston, S. H. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01261.x · Cited by 518
Kosinski, M. R., Zhao, S. Z., Dedhiya, S. D., Osterhaus, J. T., & Ware, J. E. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200007)43:7 · Cited by 502
Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis
Hashimoto, S., Ochs, R., Komiya, S., & Lotz, M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199809)41:9 · Cited by 500
A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases
Amin, A. R., Attur, M. G., Thakker, G. D., Patel, P. D., Vyas, P., Patel, R. N., Patel, I. R., & Abramson, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14014 · Cited by 474
Self-citationLanas, Á., Bajador, E., Serrano, P., Fuentes, J., Carreño, S., Guárdia, J. L., Sanz, M., Montoro, M. A., & Sainz, R. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009213431202 · Cited by 404
Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.
Sakurai, H., Kohsaka, H., Liu, M. F., Higashiyama, H., Hirata, Y., Kanno, K., Saito, I., & Miyasaka, N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118292 · Cited by 388
Amin, A. R., Attur, M. G., Patel, R. N., Thakker, G. D., Marshall, P. J., Rediske, J. J., Stuchin, S. A., Patel, I. R., & Abramson, S. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119280 · Cited by 385
Self-citation15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
Kawahito, Y., Kondo, M., Tsubouchi, Y., Hashiramoto, A., Bishop‐Bailey, D., Inoue, K., Kohno, M., Yamada, R., Hla, T., & Sano, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9652 · Cited by 374
Nitric-Oxide Mediates Suppression of Cartilage Proteoglycan Synthesis by Interleukin-1
Taşkıran, D., Stefanović-Račić, M., Georgescu, H. I., & Evans, C. H. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1426 · Cited by 369
Nitrosative Stress: Activation of the Transcription Factor OxyR
Hausladen, A., Privalle, C. T., Keng, T., DeAngelo, J., & Stamler, J. S. (1996) · Cell · doi:10.1016/s0092-8674(00)80147-6 · Cited by 359
Nitric oxide in excitable tissues: physiological roles and disease.
Christopherson, K. S., & Bredt, D. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119783 · Cited by 313
The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase.
Amin, A. R., Vyas, P., Attur, M. G., Leszczynska-Piziak, J., Patel, I. R., Weissmann, G., & Abramson, S. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7926 · Cited by 309
Self-citationStefanović-Račić, M., Stadler, J., & Evans, C. H. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360803 · Cited by 286
Amin, A. R., Cesare, P. E. D., Vyas, P., Attur, M. G., Tzeng, E., Billiar, T. R., Stuchin, S. A., & Abramson, S. B. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.2097 · Cited by 253
Self-citationBaeten, D., Boots, A. M. H., Steenbakkers, P. G. A., Elewaut, D. S., Bos, E. S., Verheijden, G. F. M., Verbruggen, G., Miltenburg, A. M. M., Rijnders, A. W. M., VEYS, E. M., et al. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200006)43:6 · Cited by 198
N -Acetylglucosamine Prevents IL-1β-Mediated Activation of Human Chondrocytes
Shikhman, A. R., Kühn, K., Alaaeddine, N., & Lotz, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5155 · Cited by 194
THE ROLE OF NITRIC OXIDE IN ARTICULAR CARTILAGE DAMAGE
Lotz, M. (1999) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70067-3 · Cited by 170
Fermor, B., Weinberg, J. B., Pisetsky, D. S., Misukonis, M. A., Banes, A. J., & Guilak, F. (2001) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(00)00049-8 · Cited by 169
Pelletier, J., Lascau-Coman, V., Jovanović, D., Fernandes, J. C., Manning, P. T., Connor, J. R., Currie, M. G., & Martel‐Pelletier, J. (1999) · PubMed · Cited by 159
Hof, R. V., Armour, K. J., Smith, L. M., Armour, K. E., Wei, X., Liew, F. Y., & Ralston, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130511497 · Cited by 158
Belmont, M. H., Levartovsky, D., Goel, A., Amin, A. R., Giorno, R. C., Rediske, J. J., Skovron, M. L., & Abramson, S. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401013 · Cited by 153
Self-citationAttur, M. G., Patel, I. R., Patel, R. N., Abramson, S. B., & Amin, A. R. (1998) · PubMed · Cited by 150
Self-citationHomandberg, G. A., Hui, F., Wen, C., Purple, C. R., Bewsey, K. E., Koepp, H. E., Huch, K., & Harris, A. I. (1997) · Biochemical Journal · doi:10.1042/bj3210751 · Cited by 140
Selective Inhibition of Inducible Nitric Oxide Synthase Exacerbates Erosive Joint Disease
McCartney-Francis, N. L., Song, X.-Y., Mizel, D. E., & Wahl, S. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2734 · Cited by 139
Attur, M. G., Dave, M. N., Cipolletta, C., Kang, P., Goldring, M. B., Patel, I. R., Abramson, S. B., & Amin, A. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002721200 · Cited by 126
Self-citationArner, E. C., & Tortorella, M. D. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380919 · Cited by 116
Homandberg, G. A., Meyers, R., & Williams, J. M. (1993) · PubMed · Cited by 106
Glucosamine therapy for treating osteoarthritis
Towheed, T., Anastassiades, T., Shea, B., Houpt, J. B., Welch, V. A., & Mc, H. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002946 · Cited by 104
Nitric oxide is a mediator of apoptosis in the rheumatoid joint
Hof, R. V., Hocking, L. J., Wright, P. K., & Ralston, S. H. (2000) · Lara D. Veeken · doi:10.1093/rheumatology/39.9.1004 · Cited by 102
Wittenberg, R. H., Willburger, R., Kleemeyer, K. S., & Peskar, B. A. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361017 · Cited by 96
Takahashi, K. A., Hashimoto, S., Kubo, T., Hirasawa, Y., Lotz, M., & Amiel, D. (2001) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(00)90024-x · Cited by 93
Boyault, S., Simonin, M.-A., Bianchi, A., Compe, E., Liagre, B., Mainard, D., Bécuwe, P., Dauça, M., Netter, P., Terlain, B. L., et al. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02614-x · Cited by 93
Nitric oxide production by superficial and deep articular chondrocytes
Hayashi, T., Abe, E., Yamate, T., Taguchi, Y., & Jasin, H. E. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400210 · Cited by 91
Clancy, R. M., Rediske, J. J., Koehne, C. F., Stoyanovsky, D. A., Amin, A., Attur, M. G., Iyama, K.-I., & Abramson, S. B. (2001) · Osteoarthritis and Cartilage · doi:10.1053/joca.2000.0388 · Cited by 91
Self-citationGlucosamine Inhibits Inducible Nitric Oxide Synthesis
Meininger, C. J., Kelly, K. A., Li, H. Z., Haynes, T. E., & Wu, G. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3912 · Cited by 88
Attur, M. G., Dave, M. N., Clancy, R. M., Patel, I. R., Abramson, S. B., & Amin, A. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2684 · Cited by 82
Self-citationAnimal models of arthritis in NOS2-deficient mice
van den Berg, W. B., van de Loo, F., Joosten, L. A. B., & Arntz, O. J. (1999) · Osteoarthritis and Cartilage · doi:10.1053/joca.1999.0228 · Cited by 80
Patel, R., Attur, M. G., Dave, M. N., Abramson, S. B., & Amin, A. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4191 · Cited by 73
Self-citationPhosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts
Nakamura, I., Sasaki, T., Tanaka, S., Takahashi, N., Jimi, E., Kurokawa, T., Kita, Y., Ihara, S., Suda, T., & Fukui, Y. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199708)172:2 · Cited by 61
Self-citationDetection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus
Griffiths, D. J., Cooke, S. P., Herv�, C., Rigby, S. P., Mallon, E., Hajeer, A. H., Lock, M., Emery, V. C., Taylor, P. C., Pantelidis, P., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199904)42:3 · Cited by 60
Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells
Hirai, Y., Migita, K., Honda, S., Ueki, Y., Yamasaki, S., Urayama, S., Kamachi, M., Kawakami, A., Ida, H., Kita, M., et al. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00998-x · Cited by 50
Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes.
Sadowski, T., & Steinmeyer, J. (2001) · PubMed · Cited by 49
Leukotriene B4 and prostaglandin E2-like activity in synovial fluid in osteoarthritis
Atik, O. Ş. (1990) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(90)90002-3 · Cited by 49
Hwa, S. Y., Burkhardt, D., Little, C. B., & Ghosh, P. (2001) · PubMed · Cited by 47
Rainsford, K. D., Ying, C., & Smith, F. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05875.x · Cited by 45
Involvement of nitric oxide in chondrocyte cell death in chondro-osteophyte formation
Nishida, K., Doi, T., Matsuo, M., Ishiwari, Y., Tsujigiwa, H., Yoshida, A., Shibahara, M., & Inoue, H. (2001) · Osteoarthritis and Cartilage · doi:10.1053/joca.2000.0380 · Cited by 29
Mechanical Stress and Nitric Oxide Influence Leukotriene Production in Cartilage
Fermor, B., Haribabu, B., Weinberg, J. B., Pisetsky, D. S., & Guilak, F. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5237 · Cited by 26
Kageyama, Y., Koide, Y., Miyamoto, S., Yoshida, T., & Inoue, T. M. N. (1994) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749409103049 · Cited by 16
Nitric oxide donating compounds inhibit HCl-induced gastric mucosal lesions mainly via prostaglandin
Uchida, M., Matsueda, K., Shoda, R., Muraoka, A., & Yamato, S. (2001) · Japanese Journal of Pharmacology · doi:10.1254/jjp.85.133 · Cited by 14
Jelaska (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200010)43:10 · Cited by 2
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Straub, R. H., & Cutolo, M. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3
Self-citationPope (2001) · doi:10.1002/1529-0131(200106)44:6
Self-citationSantiago (2001) · doi:10.1002/1529-0131(200107)44:7
Research works printed but not linked: 2
- Attur MG, Dave M, Stuchin S, et al.: Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum 2001, 44:578–584. · DOI · Paper page
- PK, Hummel KM, Schedel J, et al.: Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts. Arthritis Rheum 2001, 43:15971–1605.
Cited by
Sorted by citations
Moreland, L. W. (2003) · Arthritis Research · doi:10.1186/ar623 · Cited by 669
The Role of Cytokines in Cartilage Matrix Degeneration in Osteoarthritis
Goldring, S. R., & Goldring, M. B. (2004) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000144854.66565.8f · Cited by 655
Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes
Largo, R., Alvarez-Soria, M. A., Dı́ez-Ortego, I., Calvo, E., Sánchez‐Pernaute, O., Egido, J., & Herrero‐Beaumont, G. (2003) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(03)00028-1 · Cited by 393
Pearle, A. D., Scanzello, C. R., George, S., Mandl, L. A., DiCarlo, E. F., Peterson, M., Sculco, T. P., & Crow, M. K. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2006.10.010 · Cited by 362
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Mollace, V., Muscoli, C., Masini, E., Cuzzocrea, S., & Salvemini, D. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.1 · Cited by 356
Metadata
- Authors
- Abramson, S. B., Attur, M., Amin, A. R., & Clancy, R.
- Affiliations
- NYU Langone Health (US)
- Venue
- Current Rheumatology Reports
- Published
- 2001-12
- Volume
- 3
- Issue
- 6
- Pages
- 535-541
- ISSN
- 1523-3774 (ISSN-L)
- 1534-6307
- OpenAlex
- W2081577257
- Cited by
- 261
- References
- 63
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 10 · 2021: 9 · 2020: 18 · 2019: 15 · 2018: 14 · 2017: 13 · 2016: 15 · 2015: 10 · 2014: 12 · 2013: 13 · 2012: 12
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Rheumatology Reports (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- osteoarthritis, nitric oxide, articular chondrocytes, inflammatory mediators, inducible nitric oxide synthase, cyclooxygenase-2, prostaglandin E2, interleukin-1, inflammatory cytokines, apoptosis, cartilage degeneration, extracellular matrix, integrins, biomechanical forces, autocrine and paracrine signaling
- MeSH terms
- Cartilage, Articular, Humans, Nitric Oxide, Osteoarthritis, Cytokines, Inflammation Mediators, Nitric Oxide Synthase, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review